Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,184 | -14,470 | -9,258 | -4,278 | -16,643 |
| Depreciation Amortization | 1,670 | 1,002 | 699 | 357 | 1,149 |
| Accounts receivable | -1,662 | -349 | -910 | -17 | -1,657 |
| Other Working Capital | 934 | 468 | -1,316 | -251 | -1,219 |
| Other Operating Activity | 5,643 | 3,399 | 3,425 | 1,084 | 6,032 |
| Operating Cash Flow | $-13,599 | $-9,950 | $-7,360 | $-3,105 | $-12,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,008 | -440 | -257 | -83 | -1,374 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -2,869 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1,000 |
| Purchase Sale Intangibles | -137 | -109 | -68 | -40 | -130 |
| Other Investing Activity | -1,632 | 5,011 | 5,932 | -40 | -6,130 |
| Investing Cash Flow | $-2,640 | $4,571 | $5,675 | $-123 | $-11,373 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -83 | -44 | -29 | -14 | -452 |
| Common Stock Issued | 10,377 | 57 | 23 | N/A | 257 |
| Other Financing Activity | -150 | -270 | -119 | 0 | 0 |
| Financing Cash Flow | $10,144 | $-257 | $-125 | $-14 | $-195 |
| Beginning Cash Position | 25,554 | 25,554 | 25,554 | 25,554 | 49,460 |
| End Cash Position | 19,459 | 19,918 | 23,744 | 22,312 | 25,554 |
| Net Cash Flow | $-6,095 | $-5,636 | $-1,810 | $-3,242 | $-23,906 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,599 | -9,950 | -7,360 | -3,105 | -12,338 |
| Capital Expenditure | -1,008 | -440 | -257 | -83 | -1,374 |
| Free Cash Flow | -14,607 | -10,390 | -7,617 | -3,188 | -13,712 |